Use Of Anti-Il-17 Monoclonal Antibodies In Hiv Patients With Erythrodermic Psoriasis
CASE REPORTS IN DERMATOLOGY(2020)
摘要
Psoriasis is an immune-mediated skin disease with various presentations. HIV infection affects the immune system and aggravates psoriasis lesions. Therefore, psoriasis management in HIV patients poses a great challenge for dermatologists. In this report, 2 HIV patients with erythrodermic psoriasis received anti-IL-17 and experienced significant clearance of lesions. No recurrence or opportunistic infection was noted. In conclusion, anti-IL-17 monoclonal antibodies are an effective and promising treatment option for HIV-infected patients with psoriasis.
更多查看译文
关键词
Biologic treatment, Ixekizumab, Secukinumab, HIV psoriasis, Anti-IL-17, Erythrodermic psoriasis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要